Redmile Group, LLC Vericel Corp Transaction History

Redmile Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$13.77 - $19.2 $230,234 - $321,024	-16,720 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$10.77 - $18.44 $35,325 - $60,483	-3,280 Reduced 16.4%	16,720 $291,000
Q3 2018 Nov 14, 2018	SELL	$9.1 - $14.8 $1.46 Million - $2.38 Million	-160,873 Reduced 88.94%	20,000 $283,000
Q2 2018 Aug 14, 2018	BUY	$9.6 - $14.6 $1.74 Million - $2.64 Million	180,873 New	180,873 $1.75 Million

277

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.73B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.